Does VELAGLUCERASE ALFA Cause Nephrolithiasis? 18 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 18 reports of Nephrolithiasis have been filed in association with VELAGLUCERASE ALFA (VPRIV). This represents 1.0% of all adverse event reports for VELAGLUCERASE ALFA.
18
Reports of Nephrolithiasis with VELAGLUCERASE ALFA
1.0%
of all VELAGLUCERASE ALFA reports
1
Deaths
13
Hospitalizations
How Dangerous Is Nephrolithiasis From VELAGLUCERASE ALFA?
Of the 18 reports, 1 (5.6%) resulted in death, 13 (72.2%) required hospitalization, and 1 (5.6%) were considered life-threatening.
Is Nephrolithiasis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for VELAGLUCERASE ALFA. However, 18 reports have been filed with the FAERS database.
What Other Side Effects Does VELAGLUCERASE ALFA Cause?
Inappropriate schedule of product administration (197)
Product dose omission issue (188)
Covid-19 (163)
Fatigue (136)
Death (108)
Fall (104)
Pyrexia (101)
Malaise (98)
Weight increased (89)
Headache (88)
What Other Drugs Cause Nephrolithiasis?
ADALIMUMAB (2,416)
ETANERCEPT (1,292)
INFLIXIMAB (981)
METHOTREXATE (979)
ABATACEPT (788)
TOPIRAMATE (768)
CERTOLIZUMAB PEGOL (735)
RITUXIMAB (709)
TOFACITINIB (699)
SODIUM OXYBATE (698)
Which VELAGLUCERASE ALFA Alternatives Have Lower Nephrolithiasis Risk?
VELAGLUCERASE ALFA vs VELCADE
VELAGLUCERASE ALFA vs VELETRI
VELAGLUCERASE ALFA vs VELIPARIB
VELAGLUCERASE ALFA vs VEMURAFENIB
VELAGLUCERASE ALFA vs VENETOCLAX